Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/27/2012WO2012128576A2 Composition for treating lower or damaged cognitive function containing dehydroglyasperin c typically found in licorice
09/27/2012WO2012127878A1 A 5-ht4 receptor agonist as a prokinetic agent
09/27/2012WO2012127506A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012WO2012127475A1 Neuroprotective peptides
09/27/2012WO2012127393A1 COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
09/27/2012WO2012127392A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
09/27/2012WO2012127391A1 Composition comprising diamine oxidase for the prevention of hangover symptoms
09/27/2012WO2012127382A1 Functional foods comprising diamine oxidase and uses thereof
09/27/2012WO2012127381A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
09/27/2012WO2012127176A1 Derivatives of allopregnanolone and of epiallopregnanolone and uses thereof for treating a neuropathological condition
09/27/2012WO2012127030A1 Arylpiperazines as neuroprotective agents
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012126791A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/27/2012WO2012126770A1 Doxylamine resinate complex
09/27/2012WO2012126472A1 Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases
09/27/2012WO2012126386A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126385A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126344A1 Method for physical modification of cobra venom and application thereof in preparation of analgesic and immune suppressing drugs
09/27/2012WO2012126150A1 Peptide with analgesic activity and preparation method thereof
09/27/2012WO2012126047A1 Agent and method for treating pain and reducing inflammation
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012059442A3 Neurotrypsin inhibitors
09/27/2012WO2012020848A8 Heterocyclic compound and use thereof
09/27/2012WO2012019106A8 Compounds for use in modulating the nmda receptor
09/27/2012US20120246757 Modulation of cellular protein function by artificial sumo ligases
09/27/2012US20120245561 Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245229 Method for treating neuropathic pain
09/27/2012US20120245226 Methods for treating attention-deficit/hyperactivity disorder
09/27/2012US20120245225 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
09/27/2012US20120245224 Cannabinoids for use in the treatment of neuropathic pain
09/27/2012US20120245223 Use of gymnodimine, analogues and derivatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid
09/27/2012US20120245222 Methods of using low-dose doxepin for the improvement of sleep
09/27/2012US20120245216 Compositions and methods for treatment of neuropathic pain
09/27/2012US20120245215 Co-Crystals of Pyrrolidinones
09/27/2012US20120245211 Methods of Treating Cognitive Dysfunction by Modulating Brain Energy Metabolism
09/27/2012US20120245208 2-Oxo-1-Pyrrolidinyl Imidazothiadiazole Derivatives
09/27/2012US20120245206 Multi-cyclic compounds and methods of use
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245201 Isopropylphenidate for Treatment of Attention-Deficit/Hyperactivity Disorder and Fatigue-Related Disorders and Conditions
09/27/2012US20120245196 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
09/27/2012US20120245195 Novel monohydrate of azaadamantane derivatives
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245190 Autophagy inducing compound and the uses thereof
09/27/2012US20120245188 Methods of treating memory loss and enhancing memory performance
09/27/2012US20120245184 Small organic molecule regulators of cell proliferation
09/27/2012US20120245181 Opioid receptor ligands and methods of using and making same
09/27/2012US20120245179 Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245172 Heterocyclic amine derivatives
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245168 Composition, Synthesis, and Use of New Substituted Pyran and Pterin Compounds
09/27/2012US20120245166 Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
09/27/2012US20120245165 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
09/27/2012US20120245164 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
09/27/2012US20120245163 TRPV1 Antagonists
09/27/2012US20120245158 Gamma secretase modulators
09/27/2012US20120245155 Fused heterocyclic compound having amino group
09/27/2012US20120245154 Substituted aminothiazine derivative
09/27/2012US20120245153 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245147 Inhibitors of thapsigargin-induced cell death
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245137 Aryl sulphone derivatives as calcium channel blockers
09/27/2012US20120245136 Chroman-spirocyclic piperidine amides as modulators of ion channels
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245133 Methods for the treatment of a traumatic central nervous system injury
09/27/2012US20120245131 6-substituted estradiol derivatives for use in remyelination of nerve axons
09/27/2012US20120245129 Use of s1p receptor modulator
09/27/2012US20120245125 Pyridazine compounds, compositions and methods
09/27/2012US20120245118 Methods and compositions for alleviating stuttering
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245108 Method of modulating complement factor b (cfb) expression in cells
09/27/2012US20120245096 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
09/27/2012US20120245095 Biglycan and related therapeutics and methods of use
09/27/2012US20120245094 Compounds, compositions and use
09/27/2012US20120245093 Neuronal Viability Factor and Use Thereof
09/27/2012US20120245081 Fas peptide mimetics and uses thereof
09/27/2012US20120245078 Means and methods for treating ischemic conditions
09/27/2012US20120244234 Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission
09/27/2012US20120244223 Orally dispersible tablet
09/27/2012US20120244221 Extended-release formulation for reducing the frequency of urination and method of use thereof
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244213 Methods for the treatment of speech impediments
09/27/2012US20120244174 Treatment of tauopathies
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244167 Antibodies to m-csf
09/27/2012US20120244165 Methods of treating amyloidosis comprising the use of anti-amyloid beta antibodies
09/27/2012US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof
09/27/2012US20120244157 Use of tnf-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
09/27/2012US20120244153 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244146 Treatment of tauopathies
09/27/2012US20120244139 Modified proteases that inhibit complement activation
09/27/2012US20120244111 Pheromones and the Luteinizing Hormone for Inducing Proliferation of Neural Stem Cells and Neurogenesis
09/27/2012US20120244106 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
09/27/2012US20120244104 Nicotine containing formulation
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 1833